ATACOR MEDICAL CLOSES $28M SERIES C FINANCING TO DELIVER NEXT GENERATION EV-ICD AND PACING OPTIONS FOR CARDIAC RHYTHM MANAGEMENT
FUNDING SUPPORTS REGULATORY SUBMISSIONS AND CLINICAL MILESTONES
ATACOR MEDICAL TO PRESENT ACUTE AND 3 MONTH RESULTS
FROM EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (EV-ICD) STUDIES
ATACOR MEDICAL TO PRESENT PRELIMINARY RESULTS
FROM FIRST-IN-HUMAN EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (EV-ICD) STUDY
ATACOR MEDICAL RAISES $25M
TO CONTINUE EXTRACARDIAC PACING DEVELOPMENT
RESULTS SUPPORT FEASIBILITY OF
ENTIRELY EXTRACARDIAC, MINIMALLY INVASIVE, TEMPORARY PACING SYSTEM
ATACOR MEDICAL RAISES $8.8M
TO DEVELOP SUBSTERNAL CARDIAC PACING SYSTEM